Clinical development of the GnRH agonist leuprolide acetate depot

Leuprolide acetate is the first GnRH agonist that entered clinical development after the discovery of the native GnRH. Several long-acting depot formulations of leuprolide acetate (ranging from 1-month to 6-month intramuscular injections) have been successively developed for various suppressive trea...

Descripción completa

Detalles Bibliográficos
Autor principal: Chwalisz, Kristof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201295/
https://www.ncbi.nlm.nih.gov/pubmed/37223757
http://dx.doi.org/10.1016/j.xfre.2022.11.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201295/
https://www.ncbi.nlm.nih.gov/pubmed/37223757
http://dx.doi.org/10.1016/j.xfre.2022.11.011

Ejemplares similares